Spectral Medicals revenue up 54 percent as company eyes Tigris trial completion - Yahoo Finance
EDTXF Stock | USD 0.37 0.02 5.13% |
Roughly 62% of Spectral Med's investor base is looking to short. The analysis of overall sentiment of trading Spectral Med pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Spectral Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Spectral Med stock news signals to limit their universe of possible portfolio assets.
Spectral Med pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Spectral daily returns and investor perception about the current price of Spectral Med as well as its diversification or hedging effects on your existing portfolios.
Spectral |
Spectral Medicals revenue up 54 percent as company eyes Tigris trial completion Yahoo Finance
Read at news.google.com
Spectral Med Fundamental Analysis
We analyze Spectral Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spectral Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spectral Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Spectral Med is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Spectral Med Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spectral Med pink sheet to make a market-neutral strategy. Peer analysis of Spectral Med could also be used in its relative valuation, which is a method of valuing Spectral Med by comparing valuation metrics with similar companies.
Peers
Spectral Med Related Equities
MYNZ | Mainz Biomed | 14.04 | ||||
ENZ | Enzo Biochem | 1.67 | ||||
BMKDF | BioMark Diagnostics | 0.00 | ||||
FONR | Fonar | 0.51 | ||||
BDSX | Biodesix | 0.96 | ||||
BIAF | BioAffinity Technologies, | 1.30 | ||||
BNR | Burning Rock | 1.47 | ||||
SERA | Sera Prognostics | 2.71 | ||||
LAB | Standard Biotools | 3.73 | ||||
GH | Guardant Health | 5.93 | ||||
STIM | Neuronetics | 9.09 |
Complementary Tools for Spectral Pink Sheet analysis
When running Spectral Med's price analysis, check to measure Spectral Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectral Med is operating at the current time. Most of Spectral Med's value examination focuses on studying past and present price action to predict the probability of Spectral Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectral Med's price. Additionally, you may evaluate how the addition of Spectral Med to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |